Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, Irvine
About this trial
The purpose of this study is to assess the safety and efficacy of Micro/nanobubbles (MNB's) for the healing of acute and chronic wounds.
Eligibility criteria
Qualifiers
are above the age of 18.
have traumatic, surgical, or chronic wounds.
have radiotherapy related tissue injury.
have thermal, chemical, and/or electrical burn injuries.
Disqualifiers
have infected wounds.
have wounds with exposed vital structures such as nerves, arteries, and/or veins.
have wounds associated with malignancy.
Trial design
Treatments tested in this trial
- Micro/nanobubble (MNB) - Irrigation
- 0.9% Normal Saline - Irrigation
- Micro/nanobubble (MNB) - Negative Pressure Wound Therapy with Instillation (NPWTi)
- 0.9% Normal Saline - Negative Pressure Wound Therapy with Instillation (NPWTi)
Treatment groups
40 Participants
are divided into 4 treatment groupsLocations
1UCI Medical Center92868, OrangeCalifornia, United States
Sponsors and collaborators
University of California, Irvine
Lead sponsor
Source ClinicalTrials.gov